← Back to Clinical Trials
Recruiting NCT07119268

NCT07119268 SPARK Healthy Sleep

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07119268
Status Recruiting
Phase
Sponsor Indiana University
Condition Schizophrenia and Related Disorders
Study Type INTERVENTIONAL
Enrollment 115 participants
Start Date 2025-10-24
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
SPARK Healthy Sleep

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 115 participants in total. It began in 2025-10-24 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

SPARK-Healthy Sleep is a digital mental health intervention designed to help college students who may be at risk for psychosis and experience sleep problems. About 1 in 4 college students report psychotic-like experiences (such as hearing voices or feeling paranoid), and these students often have poor sleep quality, which can worsen their mental health symptoms. This study tests whether a single-session digital intervention can improve sleep and reduce mental health stigma in at-risk college students. The intervention is delivered through a smartphone app and takes about 30 minutes to complete. It includes educational content about mental health being on a continuum (not just "normal" vs "abnormal"), strategies to reduce stigma around seeking help, and evidence-based sleep improvement techniques based on cognitive behavioral therapy for insomnia. The study will recruit 115 college students from Indiana University-Indianapolis who score high on measures of psychotic-like experiences and poor sleep quality. Half will receive the intervention immediately (experimental group), while the other half will wait three weeks before receiving it (control group). All participants will complete questionnaires about sleep, mental health symptoms, social functioning, and stigma at the beginning of the study and after two weeks. The main goals are to determine if the intervention is feasible and acceptable to students, and whether it shows preliminary effectiveness in improving sleep quality, reducing stigma, and improving overall mental health outcomes. A subset of participants will also complete interviews about their experience using the intervention. This research addresses important barriers to mental health care for college students, including stigma and limited access to services. If successful, this digital approach could provide a scalable way to help at-risk students improve their mental health and potentially prevent more serious problems from developing.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * Current college enrollment * English fluency * Prodromal Questionnaire-Brief endorsement score ≥7 * Pittsburgh Sleep Quality Index score \>5 * Pass validity screening questions Exclusion Criteria: * Previous psychotic disorder diagnosis * Unable to provide informed consent

Contact & Investigator

Central Contact

Kyle S Minor, PhD

✉ ksminor@iu.edu

📞 317-274-2933

Frequently Asked Questions

Who can join the NCT07119268 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Schizophrenia and Related Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07119268 currently recruiting?

Yes, NCT07119268 is actively recruiting participants. Contact the research team at ksminor@iu.edu for enrollment information.

Where is the NCT07119268 trial being conducted?

This trial is being conducted at Indianapolis, United States.

Who is sponsoring the NCT07119268 clinical trial?

NCT07119268 is sponsored by Indiana University. The trial plans to enroll 115 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology